These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21542021)

  • 1. Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression.
    Remple MS; Bradenham CH; Kao CC; Charles PD; Neimat JS; Konrad PE
    Mov Disord; 2011 Aug; 26(9):1657-62. PubMed ID: 21542021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
    Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
    Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
    Maltête D; Jodoin N; Karachi C; Houeto JL; Navarro S; Cornu P; Agid Y; Welter ML
    J Neurophysiol; 2007 Jun; 97(6):4017-22. PubMed ID: 17460099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-frequency stimulation of the subthalamic nucleus increases pallidal neuronal firing rate in a patient with Parkinson's disease.
    Reese R; Steigerwald F; Pötter M; Herzog J; Deuschl G; Volkmann J; Pinsker MO; Mehdorn HM
    Mov Disord; 2008 Oct; 23(13):1945-7. PubMed ID: 18661546
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity parameters of subthalamic nucleus neurons selectively predict motor symptom severity in Parkinson's disease.
    Sharott A; Gulberti A; Zittel S; Tudor Jones AA; Fickel U; Münchau A; Köppen JA; Gerloff C; Westphal M; Buhmann C; Hamel W; Engel AK; Moll CK
    J Neurosci; 2014 Apr; 34(18):6273-85. PubMed ID: 24790198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Meidahl AC; Moll CKE; van Wijk BCM; Gulberti A; Tinkhauser G; Westphal M; Engel AK; Hamel W; Brown P; Sharott A
    Neurobiol Dis; 2019 Jul; 127():101-113. PubMed ID: 30753889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multistable properties of human subthalamic nucleus neurons in Parkinson's disease.
    Chopek JW; Hultborn H; Brownstone RM
    Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24326-24333. PubMed ID: 31712414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular spike microrecordings from the subthalamic area in Parkinson's disease.
    Mrakic-Sposta S; Marceglia S; Egidi M; Carrabba G; Rampini P; Locatelli M; Foffani G; Accolla E; Cogiamanian F; Tamma F; Barbieri S; Priori A
    J Clin Neurosci; 2008 May; 15(5):559-67. PubMed ID: 18378458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.
    Herrojo Ruiz M; Rusconi M; Brücke C; Haynes JD; Schönecker T; Kühn AA
    Brain; 2014 Oct; 137(Pt 10):2715-30. PubMed ID: 25031238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic deep brain stimulation alters neuronal firing in canonical pain nuclei in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.
    Gee LE; Walling I; Ramirez-Zamora A; Shin DS; Pilitsis JG
    Exp Neurol; 2016 Sep; 283(Pt A):298-307. PubMed ID: 27373204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Tseng KY; Kasanetz F; Kargieman L; Pazo JH; Murer MG; Riquelme LA
    Brain Res; 2001 Jun; 904(1):93-103. PubMed ID: 11516415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic nucleus neuronal firing rates in Parkinson's disease.
    Montgomery EB
    Mov Disord; 2012 Mar; 27(3):455; author reply 455-6. PubMed ID: 22266738
    [No Abstract]   [Full Text] [Related]  

  • 13. Subthalamic and nigral neurons are differentially modulated during parkinsonian gait.
    Gulberti A; Wagner JR; Horn MA; Reuss JH; Heise M; Koeppen JA; Pinnschmidt HO; Westphal M; Engel AK; Gerloff C; Sharott A; Hamel W; Moll CKE; Pötter-Nerger M
    Brain; 2023 Jul; 146(7):2766-2779. PubMed ID: 36730026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic neuronal responses to cortical stimulation.
    Janssen ML; Zwartjes DG; Temel Y; van Kranen-Mastenbroek V; Duits A; Bour LJ; Veltink PH; Heida T; Visser-Vandewalle V
    Mov Disord; 2012 Mar; 27(3):435-8. PubMed ID: 22213381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevations in local gamma activity are accompanied by changes in the firing rate and information coding capacity of neurons in the region of the subthalamic nucleus in Parkinson's disease.
    Pogosyan A; Kühn AA; Trottenberg T; Schneider GH; Kupsch A; Brown P
    Exp Neurol; 2006 Dec; 202(2):271-9. PubMed ID: 16905134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal firing patterns in the subthalamic nucleus in patients with akinetic-rigid-type Parkinson's disease.
    Guo S; Zhuang P; Zheng Z; Zhang Y; Li J; Li Y
    J Clin Neurosci; 2012 Oct; 19(10):1404-7. PubMed ID: 22898200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the neuronal firing patterns in the subthalamic nucleus with graded dopaminergic cell loss in the nigrostriatal pathway.
    Park SE; Song KI; Suh JK; Youn I
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2510-3. PubMed ID: 26736802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease.
    Piallat B; Polosan M; Fraix V; Goetz L; David O; Fenoy A; Torres N; Quesada JL; Seigneuret E; Pollak P; Krack P; Bougerol T; Benabid AL; Chabardès S
    Ann Neurol; 2011 May; 69(5):793-802. PubMed ID: 21520240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationale.
    Charles D; Tolleson C; Davis TL; Gill CE; Molinari AL; Bliton MJ; Tramontana MG; Salomon RM; Kao C; Wang L; Hedera P; Phibbs FT; Neimat JS; Konrad PE
    J Parkinsons Dis; 2012; 2(3):215-23. PubMed ID: 23938229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dexmedetomidine on the firing properties of STN neurons in Parkinson's disease.
    Krishna V; Elias G; Sammartino F; Basha D; King NK; Fasano A; Munhoz R; Kalia SK; Hodaie M; Venkatraghavan L; Lozano AM; Hutchison WD
    Eur J Neurosci; 2015 Aug; 42(4):2070-7. PubMed ID: 26108432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.